Generic name |
amifampridine |
---|---|
Strength |
10 mg |
Form |
tablet |
Special Authority criteria |
Approval period |
---|---|
Initial For the symptomatic treatment of patients with Lambert-Eaton myasthenic syndrome (LEMS) who are 6 years of age and older, when requested by a neurologist with expertise in managing LEMS |
3 months |
Renewal For the symptomatic treatment of patients with Lambert-Eaton myasthenic syndrome (LEMS) who are 6 years of age and older when:
AND
|
1 year |